









Markets
/
Stocks
/
nasdaq-lvtx
/

LAVA Therapeutics NV

LVTX

View Detailed Chart

1.420USD

0.0000.00%

Close 08/01, 16:00（ET）Quotes delayed by 15 min

37.35MMarket Cap

LossP/E TTM



LAVA Therapeutics NV

1.420

0.0000.00%

Overview Company Financials

Financials

Intraday

30m

Today

-4.70%

5 Days

-0.70%

1 Month

+7.58%

6 Months

+42.00%

Year to Date

+49.32%

1 Year

-27.92%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 4 analysts

BUY

Current Rating

1.833

Target Price

29.11%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

552

Total

Median

Average

Company name

Ratings

Analysts

LAVA Therapeutics NV

LVTX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Ionis Pharmaceuticals Inc

IONS

Exact Sciences Corp

EXAS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Sell

Sell(6)

Neutral(4)

Buy(3)

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.002

Neutral

RSI(14)

51.091

Neutral

STOCH(KDJ)(9,3,3)

34.290

Neutral

ATR(14)

0.142

High Vlolatility

CCI(14)

-37.512

Neutral

Williams %R

75.000

Sell

TRIX(12,20)

0.434

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

1.470

Sell

MA10

1.459

Sell

MA20

1.422

Sell

MA50

1.357

Buy

MA100

1.309

Buy

MA200

1.318

Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.

Ticker SymbolLVTX

CompanyLAVA Therapeutics NV

CEOMr. Stephen A. Hurly

Websitehttps://www.lavatherapeutics.com/